{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:08:49Z","timestamp":1794258529033,"version":"4.9.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Herpes simplex virus (HSV) and varicella zoster virus (VZV) are among the most commonly diagnosed infectious causes of sporadic encephalitis worldwide. Despite treatment, mortality and morbidity rates remain high, especially for HSV encephalitis. This review is intended to provide an overview of the existing scientific literature on this topic from the perspective of a clinician who is confronted with serious decisions about continuation or withdrawal of therapeutic interventions. We performed a literature review searching two databases and included 55 studies in the review. These studies documented or investigated specifically outcome and predictive parameters of outcome of HSV and\/or VZV encephalitis. Two reviewers independently screened and reviewed full-text articles meeting the inclusion criteria. Key data were extracted and presented as a narrative summary. Both, HSV and VZV encephalitis have mortality rates between 5 and 20% and complete recovery rates range from 14 to 43% for HSV and 33 to 49% for VZV encephalitis. Prognostic factors for both VZV and HSV encephalitis are older age and comorbidity, as well as severity of disease and extent of magnetic resonance imaging (MRI) lesions on admission, and delay in treatment initiation for HSV encephalitis. Although numerous studies are available, the main limiting factors are the inconsistent patient selection and case definitions as well as the non-standardised outcome measures, which hampers the comparability of the studies. Therefore, larger and standardised observational studies applying validated case definitions and outcome measures including quality of life assessment are required to provide solid evidence to answer the research question.<\/jats:p>","DOI":"10.3389\/fneur.2023.1130090","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:10:21Z","timestamp":1687781421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? A narrative review"],"prefix":"10.3389","volume":"14","author":[{"given":"Lena S.","family":"Abbuehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsany","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anelia","family":"Dietmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1212\/WNL.0b013e3181f11d65","article-title":"Challenge of the unknown: a systematic review of acute encephalitis in non-outbreak situations","volume":"75","author":"Granerod","year":"2010","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.medmal.2017.02.003","article-title":"Epidemiology of infectious encephalitis causes in 2016","volume":"47","author":"Boucher","year":"2017","journal-title":"M\u00e9decine Mal Infect"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1743-422X-5-134","article-title":"The incidence of acute encephalitis syndrome in Western industrialised and tropical countries","volume":"5","author":"Jmor","year":"2008","journal-title":"Virol J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","article-title":"Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association National Guidelines","volume":"64","author":"Solomon","year":"2012","journal-title":"J Infect"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/cid\/cis226","article-title":"Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France","volume":"54","author":"Mailles","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1471-2334-12-356","article-title":"Impact of herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome","volume":"12","author":"Poissy","year":"2012","journal-title":"BMC Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12883-021-02502-3","article-title":"Meningitis, meningoencephalitis and encephalitis in Bern: an observational study of 258 patients","volume":"21","author":"Ungureanu","year":"2021","journal-title":"BMC Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/2193-1801-3-524","article-title":"Herpes simplex encephalitis in Iceland 1987\u20132011","volume":"3","author":"Dagsd\u00f3ttir","year":"2014","journal-title":"Springerplus"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1086\/648419","article-title":"Infectious encephalitis in France in 2007: a national prospective study","volume":"49","author":"Mailles","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3201\/eid1909.130064","article-title":"New estimates of incidence of encephalitis in England","volume":"19","author":"Granerod","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","article-title":"The Management of Encephalitis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.antiviral.2006.04.002","article-title":"Herpes simplex encephalitis: adolescents and adults","volume":"71","author":"Whitley","year":"2006","journal-title":"Antivir Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","article-title":"Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management","volume":"13","author":"Bradshaw","year":"2016","journal-title":"Neurotherapeutics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1056\/NEJM198601163140303","article-title":"Vidarabine versus acyclovir therapy in herpes simplex encephalitis","volume":"314","author":"Whitley","year":"1986","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(84)92623-0","article-title":"Acyclovir versus vidarabine in herpes simplex encephalitis","volume":"2","author":"Sk\u00f6ldenberg","year":"1984","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/ene.13356","article-title":"EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis","volume":"24","author":"Taba","year":"2017","journal-title":"Eur J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jnnp.63.3.321","article-title":"Herpes simplex encephalitis treated with acyclovir: diagnosis and long-term outcome","volume":"63","author":"McGrath","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref21","first-page":"180","article-title":"The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors","volume":"10","author":"Utley","year":"1997","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1086\/341405","article-title":"Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study","volume":"35","author":"Raschilas","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2169\/internalmedicine.43.796","article-title":"Serial changes of intrathecal viral loads evaluated by Chemiluminescence assay and nested PCR with Aciclovir treatment in herpes simplex virus encephalitis","volume":"43","author":"Kamei","year":"2004","journal-title":"Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/jnnp.2004.049676","article-title":"Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis","volume":"76","author":"Kamei","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cyto.2009.01.004","article-title":"Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis","volume":"46","author":"Kamei","year":"2009","journal-title":"Cytokine"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2169\/internalmedicine.48.1445","article-title":"Predictors of a prolonged clinical course in adult patients with herpes simplex virus encephalitis","volume":"48","author":"Taira","year":"2009","journal-title":"Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00415-009-5106-6","article-title":"Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis","volume":"256","author":"Hjalmarsson","year":"2009","journal-title":"J Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eimc.2008.05.006","article-title":"Adult herpes simplex encephalitis: fifteen years\u2019 experience","volume":"27","author":"Riera-Mestre","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1017\/S0950268811000483","article-title":"Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France","volume":"140","author":"Stahl","year":"2012","journal-title":"Epidemiol Infect"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1212\/WNL.0b013e3182752ceb","article-title":"Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised","volume":"79","author":"Tan","year":"2012","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10072-013-1475-9","article-title":"Herpes simplex encephalitis: clinical presentation, neurological sequelae and new prognostic factors. Ten years of experience","volume":"34","author":"Riancho","year":"2013","journal-title":"Neurol Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jcv.2014.03.010","article-title":"Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients","volume":"60","author":"Sili","year":"2014","journal-title":"J Clin Virol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13054-015-1046-y","article-title":"Long-term outcome of severe herpes simplex encephalitis: a population-based observational study","volume":"19","author":"Jouan","year":"2015","journal-title":"Crit Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/cid\/civ369","article-title":"Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy","volume":"61","author":"Gnann","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.cmi.2020.09.031","article-title":"Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis","volume":"27","author":"Westman","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cmi.2016.07.028","article-title":"N-methyl-D-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis","volume":"22","author":"Westman","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1128\/AAC.05016-14","article-title":"Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis","volume":"59","author":"Erdem","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"568.e9","DOI":"10.1016\/j.cmi.2016.03.027","article-title":"Managing atypical and typical herpetic central nervous system infections: results of a multinational study","volume":"22","author":"Cag","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2016.05.017","article-title":"Can we differentiate between herpes simplex encephalitis and Japanese encephalitis?","volume":"366","author":"Kalita","year":"2016","journal-title":"J Neurol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3988\/jcn.2016.12.2.224","article-title":"Prognostic value of initial standard EEG and MRI in patients with herpes simplex encephalitis","volume":"12","author":"Kim","year":"2016","journal-title":"J Clin Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00415-015-7960-8","article-title":"Predictors of outcome in HSV encephalitis","volume":"263","author":"Singh","year":"2016","journal-title":"J Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jinf.2016.09.004","article-title":"Incidence and mortality of herpes simplex encephalitis in Denmark: a nationwide registry-based cohort study","volume":"74","author":"J\u00f8rgensen","year":"2017","journal-title":"J Infect"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s15010-018-1257-7","article-title":"Challenges in HSV encephalitis: normocellular CSF, unremarkable CCT, and atypical MRI findings","volume":"47","author":"Bewersdorf","year":"2019","journal-title":"Infection"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s42466-019-0031-3","article-title":"The German trial on Aciclovir and corticosteroids in herpes-simplex-virus-encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial","volume":"1","author":"Meyding-Lamad\u00e9","year":"2019","journal-title":"Neurol Res Pract"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"773","DOI":"10.14740\/jocmr4025","article-title":"Herpes simplex virus encephalitis: patterns of epidemiology and outcomes of patients admitted to the intensive care unit in Texas, 2008 - 2016","volume":"11","author":"Oud","year":"2019","journal-title":"J Clin Med Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00134-019-05684-0","article-title":"Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study","volume":"45","author":"Jaquet","year":"2019","journal-title":"Intensive Care Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e2114328","DOI":"10.1001\/jamanetworkopen.2021.14328","article-title":"Assessment of magnetic resonance imaging changes and functional outcomes among adults with severe herpes simplex encephalitis","volume":"4","author":"Sarton","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.1097\/CCM.0000000000005485","article-title":"Herpes simplex virus encephalitis with initial negative polymerase chain reaction in the cerebrospinal fluid: prevalence, associated factors, and clinical impact","volume":"50","author":"de Montmollin","year":"2022","journal-title":"Crit Care Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2147\/CLEP.S256838","article-title":"Long-term survival, morbidity, social functioning and risk of disability in patients with a herpes simplex virus type 1 or type 2 central nervous system infection, Denmark, 2000\u20132016","volume":"12","author":"Hansen","year":"2020","journal-title":"Clin Epidemiol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejca.2022.08.009","article-title":"Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: a retrospective multicentre cohort study","volume":"175","author":"M\u00fcller-Jensen","year":"2022","journal-title":"Eur J Cancer"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1007\/s00415-022-10981-8","article-title":"Herpetic encephalitis: which treatment for which body weight?","volume":"269","author":"Mulatero","year":"2022","journal-title":"J Neurol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1469-0691.2007.01831.x","article-title":"High variability in viral load in cerebrospinal fluid from patients with herpes simplex and varicella-zoster infections of the central nervous system","volume":"13","author":"R\u016f\u017eek","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s15010-015-0867-6","article-title":"Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes","volume":"44","author":"Kaewpoowat","year":"2016","journal-title":"Infection"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s13365-016-0452-5","article-title":"A study on viral CNS inflammation beyond herpes encephalitis","volume":"22","author":"Jordan","year":"2016","journal-title":"J Neurovirol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e27856","DOI":"10.1097\/MD.0000000000027856","article-title":"Herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult population with aseptic meningitis or encephalitis: a nine-year retrospective clinical study","volume":"100","author":"Lee","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00430-003-0202-1","article-title":"Quantitative real time PCR detection of varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease","volume":"194","author":"Aberle","year":"2005","journal-title":"Med Microbiol Immunol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jcv.2009.07.014","article-title":"Varicella-zoster virus CNS disease-Viral load, clinical manifestations and sequels","volume":"46","author":"Persson","year":"2009","journal-title":"J Clin Virol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1469-0691.2011.03705.x","article-title":"Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients","volume":"18","author":"De Broucker","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00415-013-7057-1","article-title":"Cognitive impairment 3 years after neurological varicella-zoster virus infection: a long-term case control study","volume":"260","author":"Grahn","year":"2013","journal-title":"J Neurol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/S00415-013-6883-5","article-title":"Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections","volume":"260","author":"Grahn","year":"2013","journal-title":"J Neurol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/JMV.23902","article-title":"Clinical features, outcomes, and cerebrospinal fluid findings in adult patients with central nervous system (CNS) infections caused by varicella-zoster virus: comparison with enterovirus CNS infections","volume":"86","author":"Hong","year":"2014","journal-title":"J Med Virol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.diagmicrobio.2014.02.015","article-title":"Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection","volume":"79","author":"Rottenstreich","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3137-2","article-title":"Varicella zoster virus infections in neurological patients: a clinical study","volume":"18","author":"Skripuletz","year":"2018","journal-title":"BMC Infect Dis"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s13365-020-00872-x","article-title":"Clinical spectrum and prognosis of neurological complications of reactivated varicella-zoster infection: the role of immunosuppression","volume":"26","author":"Corral","year":"2020","journal-title":"J Neurovirol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/J.MEDMAL.2019.08.005","article-title":"Varicella zoster virus infection of the central nervous system in a tertiary care center in Lebanon","volume":"50","author":"Tabaja","year":"2020","journal-title":"M\u00e9decine Mal Infect"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s10096-021-04245-y","article-title":"Characteristics and outcome of varicella-zoster virus central nervous system infections in adults","volume":"40","author":"Le Bot","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/cid\/ciaa185","article-title":"Varicella zoster virus encephalitis in Denmark from 2015 to 2019-a Nationwide prospective cohort study","volume":"72","author":"Herlin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/infdis\/jiab013","article-title":"Characteristics and long-term prognosis of Danish patients with varicella zoster virus detected in cerebrospinal fluid compared with the background population","volume":"224","author":"Omland","year":"2021","journal-title":"J Infect Dis"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"e2455","DOI":"10.1002\/brb3.2455","article-title":"Neurological complications of varicella zoster virus reactivation: prognosis, diagnosis, and treatment of 72 patients with positive PCR in the cerebrospinal fluid","volume":"12","author":"Lenfant","year":"2022","journal-title":"Brain Behav"},{"key":"ref71","first-page":"491","article-title":"Meningitis\/meningoencephalitis caused by varicella zoster virus reactivation: a retrospective single-center case series study","volume":"14","author":"Yan","year":"2022","journal-title":"Am J Transl Res"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13613-022-01002-y","article-title":"Neurologic outcome of VZV encephalitis one year after ICU admission: a multicenter cohort study","volume":"12","author":"Mirouse","year":"2022","journal-title":"Ann Intensive Care"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","article-title":"Assessment of outcome after severe brain damage. A practical scale","volume":"305","author":"Jennett","year":"1975","journal-title":"Lancet"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.mayocp.2013.12.003","article-title":"Herpes simplex virus 2 encephalitis in adults","volume":"89","author":"Mateen","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e041808","DOI":"10.1136\/bmjopen-2020-041808","article-title":"Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis","volume":"11","author":"Whitfield","year":"2021","journal-title":"BMJ Open"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/QCO.0000000000000647","article-title":"Central nervous system infections produced by varicella zoster virus","volume":"33","author":"Nagel","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1386-6532(02)00020-3","article-title":"Acute central nervous system complications in varicella zoster virus infections","volume":"25","author":"Koskiniemi","year":"2002","journal-title":"J Clin Virol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2471\/BLT.09.071357","article-title":"Disability after encephalitis: development and validation of a new outcome score","volume":"88","author":"Lewthwaite","year":"2010","journal-title":"Bull World Health Organ"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"145","DOI":"10.7861\/clinmed.2021-0505","article-title":"How should we define a \u2018good\u2019 outcome from encephalitis? A systematic review of the range of outcome measures used in the long-term follow-up of patients with encephalitis","volume":"22","author":"Van Den","year":"2022","journal-title":"Clin Med (Northfield Il)"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1468-1331.2010.02970.x","article-title":"Viral meningoencephalitis: a review of diagnostic methods and guidelines for management","volume":"17","author":"Steiner","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/BF00327535","article-title":"Advantage of magnetic resonance imaging in the diagnosis of cerebral infections","volume":"29","author":"Schroth","year":"1987","journal-title":"Neuroradiology"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.medmal.2017.01.002","article-title":"IRM des enc\u00e9phalites aigu\u00ebs infectieuses de l\u2019adulte","volume":"47","author":"Bertrand","year":"2017","journal-title":"Med Mal Infect"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1130090\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:10:28Z","timestamp":1687781428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1130090\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":82,"alternative-id":["10.3389\/fneur.2023.1130090"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1130090","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fneur.2023.1130090.s001","asserted-by":"subject"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"article-number":"1130090"}}